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Abstract
Background: The health-related quality of life (HRQOL) of hypertensives may be influenced by blood pressure,
adverse effects of drugs used to treat hypertension, or other factors, such as the labelling effect, or beliefs and
attitudes about illness and treatment. There is paucity of information on the determinants of HRQOL among
black hypertensives especially in the developing countries such as Nigeria. This study describes the HRQOL and
its determinants among black patients diagnosed and treated for Hypertension in Nigeria.
Methods: The study was a cross sectional in design that involved 265 hypertensive patients receiving treatment
at the medical outpatient unit of the Federal Medical Centre Abeokuta, Nigeria. They were all consecutive
patients that presented at the hospital during the period of the study who meet the inclusion criteria and
consented to participate in the study. Demographic data, disease characteristics such as symptoms and signs and
recent drug history were obtained from the patients and their hospital records as documented by the physician.
The SF-36 questionnaire was administered once by interview to the participants to measure their HRQOL.
Descriptive statistics was used in summarizing the demographic data and hypertension related histories of the
participants. Multiple linear regression was used to model for the influence of socio demographic and clinical
variables of the hypertensives on their HRQOL.
Results: Physical functioning domain mean score was far below average (33.53 ± 29.65). Role physical and role
emotional domains were a little above average (54.7 ± 40.4, 51.1 ± 40.6 respectively). Role Physical (p = 0.043),
Role Emotional (p = 0.003), Vitality (p = 0.014) and Mental Health (p = 0.034) domain mean scores for patients
with controlled BP were significantly higher than patients with uncontrolled BP. The overall HRQOL was
significantly better in the group of hypertensives with controlled blood pressure (p = 0.014). Increasing blood
pressure (p = 0.005) and symptom count (p < 0.001), the presence of stroke (p = 0.008) and visual impairment
(p = 0.015) were significant negative predictors of the overall HRQOL.
Conclusion: This study provides evidence for a model that links patients' status with regard to biology (blood
pressure), symptoms, and functionality (HRQOL) and may prove useful in guiding follow-up of patients who
receive treatment for hypertension. Identification of patient's symptoms, blood pressure, complication/
comorbidity and changes in functioning may help clinicians increase their effectiveness in helping patients maintain
adherent behaviour with drug and non drug interventions in chronic diseases such as hypertension.
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Background
Hypertension is a condition with tremendous financial
and public health impact. The cost of inadequately con-
trolled blood pressure can be measured financially and
medically with financial impact in the United States being
US$47.2 billion in direct and indirect cost in 2001[1]. The
long term medical consequences of untreated hyperten-
sion such as myocardial infarction, stroke, congestive
heart failure and renal failure are among the most com-
mon and serious cause of morbidity and mortality in
Nigeria [2].
Although hypertension, especially in mild to moderate
stages, is usually considered as an asymptomatic condi-
tion, its association with alterations in well-being and
health-related quality of life (HRQOL) is still a controver-
sial issue [3]. The relationships between patient, disease,
treatment variables, symptoms, and HRQOL were
described by Wilson & Cleary [4]. This model proposes
that physiologic changes due to illness or treatment, lead
to symptoms, which in turn influences functional status
or HRQOL. These relationships are influenced by patient
and environmental variables that may affect patient per-
ception of symptoms and changes in HRQOL. This gen-
eral model can be applied to data from clinical studies to
ascertain the strength of relationships between HRQOL
and patient, disease, and treatment variables. A hyperten-
sion diagnosis may increase an individual's awareness of
bodily symptoms and make an otherwise "healthy" per-
son ill [5]. The Medical Outcome Study in America found
lower general health perception in hypertensive patients
compared with those patients without chronic conditions
[6]. In a recent population based study, hypertensive indi-
viduals were found to have lower health status compared
with individuals free from hypertension [7]. Co-morbid-
ity with other diseases associated with hypertension may
influence how persons with hypertension rate their
HRQOL. In some studies, it has been argued that the low
health-related quality of life among those with hyperten-
sion is due to subsequent complications of the disease,
not to hypertension in itself [5,8].
The profile and predictor of HRQOL of hypertensive
patients has been documented in studies from non-black
populations ([4,5,9], and [10]). Hypertension is more
prevalent in black population and presents with more
severe organ complications and accelerated course of
hypertension-induced target organ damage [11-14]. These
factors may affect the profile and predictor of HRQOL in
African hypertensive patients. Other factors that may
affect HRQOL of hypertensives are blood pressure,
adverse effects of drugs used to treat hypertension, label-
ling effect, or beliefs and attitudes about illness and treat-
ment ([4,5,9], and [10]). The knowledge of HRQOL of
hypertensive patients being a reliable determinant of cer-
ebrovascular diseases (CVDs) events will be useful in
reducing the incidence of CVDs [4,5,9,15]. This study doc-
uments the HRQOL of hypertensive patients and its pre-
dictors in a tertiary health institution located in Abeokuta,
south-western Nigeria. Knowledge of any deviation in
HRQOL in this population subgroup maybe useful in
planning therapeutic interventions that will ensure desir-
able HRQOL and not just the control of blood pressure.
Methods
Study population and design
This study was designed as descriptive cross sectional,
documenting HRQOL in patients being managed for
hypertension at the medical outpatient clinic of Federal
Medical Centre Abeokuta. Participants were all consecu-
tive patients, who had been diagnosed of being hyperten-
sive (recently and formerly diagnosed) receiving
treatment at the medical outpatient clinic. The clinic runs
four times a week with an average attendance of 200
patients weekly. All hypertensive patients seen at the clinic
during the period of this study (three months) who met
the inclusion criteria were invited to participate in this
study. Sample size was determined using data from a pre-
vious study [10], where the SD for HRQOL scores in a
similar population of hypertensive patients was 9.3 and
assuming an alpha of 0.05 and beta of 0.10 and a 2 tailed
test with a difference of a fifth of the SD. It was necessary
to involve 263 participants in the study. They were
recruited when they presented for Medical Outpatient fol-
low up clinics. Participation in the study was totally vol-
untary and subjects were asked to complete the
questionnaire by interview after their informed consent
had been sought and obtained in writing. Ethical approval
for the study was given by the Federal Medical Centre
Health research committee. The socio demographic fac-
tors included in this study were gender, age, ethnic group,
marital status, religious affiliation, educational status,
social class. Marital status was categorized as married, sin-
gle and widowed. Educational status was divided into
four levels; no education, primary education, secondary
education, and tertiary education. Social class was divided
into three categories: blue collar workers, white collar
workers and self employed [4].
Clinical and disease characteristics included in this study
were symptom counts, symptom prevalence, pattern of
antihypertensive regimen, co morbidities/complications,
body mass index (BMI), self reported duration of hyper-
tension diagnosis, status of hypertension control, height
& weight of patient, blood pressure (BP) and mean arte-
rial blood pressure (MABP). Symptom counts [10] were
measured as number of symptoms reported by the
patients during interview out of the checklist of symptoms
commonly observed in hypertension (headaches, fatigue,
blurred vision, frequent insomnia, dizziness, facial flush-
ing)[16,17]. Pattern of antihypertensive regimen[18] was
divided into six categories: diuretics only, calcium block-BMC Cardiovascular Disorders 2009, 9:25 http://www.biomedcentral.com/1471-2261/9/25
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ers only, angiotensin converting enzyme (ACE) inhibitors
only, beta blockers only, centrally acting antihypertensive
only and combination therapy. Co morbidities and com-
plications were measured as any other diagnosis reported
by the patient other than hypertension. Patient's weight,
height and blood pressure were recorded as documented
in their hospital records. The average of the three most
recent hospital records of these measurements was used
for data analysis. Patient's BMI was computed from the
weight and height records. MABP [19] was computed
from the systolic and diastolic blood pressure records. Sta-
tus of hypertension control was classified as controlled
and uncontrolled hypertension using the 140/90 mmHg
criterion [20].
Measure of health-related quality of life
The Short Form-36 (SF-36) Health Survey, version 2.0
[21] was used to assess HRQOL. Its validity, reproducibil-
ity and responsiveness to change over time have been well
demonstrated [21]. It has 36 items that measures the
health concepts of physical functioning, role limitations
due to physical health problems, bodily pain, general
health, vitality, social function, role limitations due to
emotional problems, and mental health. It also contains
a single item that examines change in health over time.
Summary measures of physical health (Physical Compo-
nent Summary [PCS]), mental health (Mental Compo-
nent Summary [MCS]) and Total QOL score (T-score)
were derived from the completed questionnaire. This
instrument was translated to Yoruba language (the local
language of the study location) by an expert linguist. For-
ward and backward translation was done during this
translation to ensure content validity. The Yoruba Lan-
guage version was administered to respondents who were
not proficient in English language. The SF-36 was admin-
istered once by interview to the participants. Estimated
duration for administration of the instrument was 15
minutes. Three trained research assistants were employed
to administer the questionnaires and obtain relevant clin-
ical information from the respondents by clinical history
and from the hospital case files of the respondents.
Statistical analyses
Descriptive statistics was used in summarizing the demo-
graphic data and Hypertension related histories of the par-
ticipants. The association between QOL scores, socio
demographic and clinical variables were determined
using stepwise multiple linear regression analyses with
QOL score as the outcome variable, while socio demo-
graphic and clinical variables were predictor variables.
Duration of hypertension diagnosis, age and MABP of
respondents were used as continuous predictor variables
while other non-linear categorical predictor variables
were dichotomized for the purpose of the multiple linear
regressions. The p-value for addition to the model was p <
0.05 and for removal from model p > 0.1. A p < 0.05 was
considered statistically significant; confidence interval
was calculated for the β-estimate.
Table 1: Socio-demographic characteristics of respondents
Classification Characteristics Frequency (Total = 265) Percentage
Gender Male 115 43.4
Female 150 56.6
Marital Status Single 8 3
Married 202 76.2
Widowed 55 20.8
Ethnic Grouping Yoruba 257 97
Ibo 8 3
Religious Affiliation Christianity 176 66.4
Islam 88 33.2
Traditional 1 0.4
Educational Status None 76 28.7
Primary 42 15.8
Secondary 62 23.4
Tertiary 85 32.1
Social Class White Collar 99 37.4
Self Employed 91 34.3
Blue Collar 22 8.3
Missing 53 20
Age 30–39 3 1.1
40–49 22 8.3
50–59 70 26.4
>60 162 61.1
Unknown age 8 3.0BMC Cardiovascular Disorders 2009, 9:25 http://www.biomedcentral.com/1471-2261/9/25
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Results
Three hundred hypertensive patients were invited to par-
ticipate in this study out of which 265 participated thus
giving a response rate of 85.3%. Twenty five (8.3%)
patients declined to participate due to personal reasons
while 10 (3.3%) patients did so due to lack of interest. The
mean age of the 265 hypertensive patients who partici-
pated was 62.4 ± 10.7 years. Less than half of the respond-
ents (43.4%) were male and 32.1% had tertiary
education. About three-quarter (76.2%) of the respond-
ents were married and 97.7% of them were of the Yoruba
tribe. Few of them (8.3%) were blue collar workers and
66.4% of the respondents were Christians. Although
50.6% had no symptoms, the most prevalent symptom
reported was frequent insomnia in 37% of respondents.
Diabetes Mellitus was the most frequent co morbidities/
complication in 23.6% of respondents. Anti-hypertensive
medication prescribed was mainly combination therapy
in 65.7% of respondents. The mean duration of hyperten-
sion diagnosis for respondents was 4.7 ± 6.1 years. Blood
pressure was controlled in 52.1% of the respondents (that
is systolic and diastolic blood pressure was less than 140/
90 mmHg). Table 1 and 2 shows the respondents socio-
demographic and clinical characteristics respectively.
Table 3 shows the mean and standard deviation of
respondents' quality of life (QOL) score by domains. The
Physical Functioning domain mean score was far below
average. Role Physical and Role Emotional domains were
a little above average. Other domains were far above aver-
age. Role Physical (p = 0.043), Role Emotional (p =
0.003), Vitality (p = 0.014) and Mental Health (p = 0.034)
domain mean scores for patients with controlled BP were
significantly higher than patients with uncontrolled BP.
Table 4 shows the comparison of mean QOL summary
measures score for respondents with controlled and
uncontrolled blood pressure. There was a significant dif-
ference between the Mental Component summary (MCS)
score (p = 0.004) and Total (T) QOL (p = 0.014) score
between the two groups of hypertensive patient with
respondents who have controlled blood pressures having
higher mean scores. Tables 5, 6 and 7 show the variables
that had significant influence on the QOL summary
scores.
Table 8 shows the result of multivariate analysis relating
MCS score to predictor variables. Increasing MABP (p =
0.013), increasing symptom count (p < 0.001), the pres-
ence of Stroke (p < 0.001) and visual impairment (p =
0.005) were significant negative predictors of the MCS
score. Educational status (p = 0.040) is a significant posi-
tive predictor of MCS score. Table 9 shows the result of
multivariate analysis relating PCS score to predictor varia-
bles. Increasing BMI (p = 0.005) and symptom count (p <
0.001) are significant negative predictors of the PCS score.
Multivariate analysis relating T-QOL score with predictor
variables revealed that increasing MABP (p = 0.005) and
symptom count (p < 0.001), and the presence of Stroke (p
= 0.008) and visual impairment (p = 0.015) were signifi-
cant negative predictors of HRQOL (Table 10).
Discussion
Many studies [4,5,9,10] have analysed HRQOL among
persons with hypertension using a comprehensive generic
instrument and with a multivariate approach to identify
association that are independent of socio-demographic
factors. However these studies are from developed coun-
tries and may not give a true picture of the profile of
HRQOL in hypertensives in a developing country like
Nigeria. In this study, the impact of hypertension on the
dimensions in the SF-36 while adjusting for socio demo-
graphic and clinical characteristics of the hypertensive
patient was investigated. The obtained data provide infor-
mation on HRQOL across a range of domains among
individuals receiving treatment for hypertension in a terti-
ary health centre.
Profile of HRQOL
In this study the Physical Functioning domain mean score
was far below average (33.53 ± 29.65). Role Physical
Table 2: Clinical variables of the respondents
clinical variables Frequency Percentage
Symptom counts
No symptom 134 50.6
1 symptom 88 33.2
2 symptoms 23 8.7
>3 symptoms 20 7.5
Comorbidities/complications
Angina Pectoris 5 1.9
Diabetes 63 23.6
Nephropathy 2 0.8
Stroke 10 3.9
Myocardial Infarct 1 0.4
Heart failure 6 2.3
Visual impairment 34 12.8
Body mass index BMI (kg/m2)
<19 19 7.2
19 – 25 140 52.7
26 – 30 54 20.5
31 and above 52 19.7
Duration of hypertension (years.)
0.3–3.9 173 65.3
4.0 – 10.9 55 20.9
11 – 30 37 13.8
Prevalence of symptoms
Headache 28 10.6
Fatigue 21 7.9
Blurred vision 25 9.4
Frequent Insomnia 98 37.0
Dizziness 16 6.0
Facial Flushing 12 4.5
Tinnitus 16 6.0BMC Cardiovascular Disorders 2009, 9:25 http://www.biomedcentral.com/1471-2261/9/25
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(presence of physical problems) and Role Emotional
(presence of emotional problems) domains were a little
above average (54.66 ± 40.36, 51.14 ± 40.58 respectively).
Other domains were far above average. These domain
scores are far lower than those presented by Bardage &
Isacson [4], (Physical functioning, 70.90 ± 27.40; Role
physical, 66.50 ± 41.50; Role emotional, 77.20 ± 37.40).
This shows that on the average the HRQOL of the popula-
tion in this study is lower than that from the study by
Bardage & Isacson [4] which was a population based study
of hypertensives but this study is a hospital based study.
The differences in HRQOL scores can be due to the fact
that hypertensives seen at hospitals have more health lim-
itation compared to those seen in the general population.
Furthermore, the study population are black hypertensive
patients; and hypertension has been said to be more prev-
alent with severe complications in this population [11-
14] hence a worse profile of HRQOL than non black pop-
ulation. Also extrinsic factors like the differences in devel-
opment and economic strength of the two study
populations may explain the differences in the HRQOL
but this study did not explore this fact.
HRQOL and Control of blood pressure
The QOL of hypertensives who had controlled blood pres-
sure and those with uncontrolled blood pressure was
compared. The physical component summary (PCS) score
of the QOL was not significantly different (p = 0.16)
between the two groups of hypertensives but the mental
component summary (MCS) score and the total T-QOL
score were significantly different (p = 0.004 & 0.014
respectively) for the two groups of hypertensives. Shapiro
et al[22], reported behavioural impairments in patients
with elevated blood pressure and Mena-Martins et al [5],
and Wie et al [9], showed that the HRQOL of hyperten-
sives improve when control of blood pressure is achieved.
This study also shows that the MCS and T-QOL score of
hypertensive who had controlled blood pressure was sig-
nificantly higher than those with uncontrolled blood
pressure hence better quality of life. Elevated blood pres-
sure is mostly without physical symptoms [17] as seen in
more than half of the respondents; this may explain why
PCS score of hypertensives with controlled and uncon-
trolled blood pressure was not significantly different.
Predictors of HRQOL
Results from multiple regression analysis revealed that a
hypertensive that has a low blood pressure (MABP less
than 108), no symptom, any form of education, and does
not have a stroke or visual impairment would have a bet-
ter mental component of HRQOL than any hypertensive
who does not have these characteristics. A hypertensive
patient who has BMI less than 30 (not obese) and no
symptom will have a better physical component of
HRQOL than any hypertensive patient who does not have
these characteristics. Also, a hypertensive patient who has
blood pressure (MABP) less than108, no symptom and
who does not a have stroke or visual impairment will have
a better overall HRQOL than a hypertensive who does not
have these characteristics. The adverse influence of
Table 4: Comparison of Mean QOL score for Respondents with Controlled and Uncontrolled Blood Pressure
Mean ± SD
Total Controlled BP Uncontrolled BP p-value
Physical component summary (PCS) score 56.54 ± 15.75 57.83 ± 15.53 55.13 ± 15.93 0.164
Mental component
(MCS) score
69.21 ± 17.66 72.16 ± 18.18 65.01 ± 16.53 0.004*
Total quality of life
(T-QOL) score
62.74 ± 15.61 65.01 ± 15.66 60.28 ± 15.24 0.014*
* = significant at < 0.05
Table 3: Mean and standard deviation of Respondents' (QOL) domain scores
Mean ± SD P-value
Domains Total Patients with Controlled BP Patients with Uncontrolled BP
Physical Functioning 33.53 ± 29.65 32.25 ± 29.73 34.93 ± 29.63 0.464
Role Physical 54.66 ± 40.36 59.49 ± 41.47 49.41 ± 38.59 0.043*
Role Emotional 51.14 ± 40.58 58.21 ± 39.48 43.39 ± 40.51 0.003*
Vitality 79.85 ± 14.57 81.94 ± 14.19 77.55 ± 14.18 0.014*
Mental Health 70.65 ± 17.87 72.86 ± 17.48 68.20 ± 18.03 0.034*
Social Functioning 75.19 ± 22.97 75.63 ± 24.09 74.70 ± 21.76 0.743
Bodily Pain 76.28 ± 30.17 77.54 ± 28.86 74.90 ± 31.60 0.479
* = significant at < 0.05BMC Cardiovascular Disorders 2009, 9:25 http://www.biomedcentral.com/1471-2261/9/25
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increasing blood pressure on HRQOL has been well doc-
umented in literature[4,5,9,15,23] but very few stud-
ies[10] have emphasized the effects of symptoms on
HRQOL of hypertensive patients. Though hypertension is
seen as an asymptomatic condition, increasing symptom
count and blood pressure is a major determinant of the
HRQOL of hypertensives. Erickson et al[10] concluded
that symptom count and symptom distress score are the
major predictors of HRQOL in hypertensives. Evidence
from this study shows that symptom count and blood
pressure are the major predictors of HRQOL of hyperten-
sive patients. This result does not essentially contradict the
study by Erickson et al[10], since increasing blood pres-
sure produces increasing symptoms and distress in hyper-
tensive patients. Symptom monitoring and management
are central to the improvement of patients' HRQOL. The
adverse effects of having a stroke on HRQOL of hyperten-
sive patients has been well documented[4,5,9] but the
Table 7: Influence of variables on T – QOL score
Variable Sub-group Mean ± SD Test statistic value p-value
Education status Any Edu. 64.41 ± 14.85 -2.78b 0.006*
No Edu. 58.59 ± 16.76
BMI Obese 56.49 ± 16.80 -3.27b 0.001*
Not Obese 64.25 ± 14.99
Symptom count No symptom 58.20 ± 12.98 -5.03b < 0.001*
≥ 1 symptom 67.46 ± 16.76
Stroke Yes 51.31 ± 11.67 -3.03b 0.01*
No 62.88 ± 15.68
Visual impairment Yes 54.38 ± 12.11 -3.23b < 0.001*
No 63.63 ± 15.79
b = t-value, * = significant at < 0.05
Table 6: Influence of variables on Mental Component Summary (MCS) score
Variable Sub-group Mean ± SD Test statistic value p-value
Education status Any Educ. 71.80 ± 17.09 -3.89b < 0.001*
No Educ. 62.66 ± 17.47
Marital status Married 70.75 ± 17.26 2.59b 0.01*
Single 64.17 ± 18.14
Occupational class White collar 72.42 ± 16.67 4.47a 0.01*
Self empl. 65.94 ± 18.37
Blue collar 63.00 ± 18.46
BMI Obese 62.82 ± 16.81 2.90b 0.004*
Not obese 70.71 ± 17.59
Symptom count No symptom 64.78 ± 15.39 -4.29b < 0.001*
≥ 1 symptom 73.86 ± 18.73
Stroke Yes 52.68 ± 16.42 -2.99b 0.003*
No 69.49 ± 17.43
Visual impairment Yes 56.93 ± 14.99 -4.80b < 0.001*
No 70.63 ± 17.34
a = f-value, b = t-value, * = significant at < 0.05
Table 5: Influence of variables on Physical component summary (PCS) score
Variable Sub-group Mean ± SD Test statistic value p-value
Symptom count No symptom 51.62 ± 13.99 10.71b < 0.001*
≥ 1 symptom 61.63 ± 15.96
BMI Obese 51.36 ± 16.96 -2.66b 0.008*
Not Obese 57.79 ± 15.25
Visual impairment Yes 51.84 ± 12.76 -2.07b 0.04*
No 56.95 ± 16.19
b = t-value, * = significant at < 0.05BMC Cardiovascular Disorders 2009, 9:25 http://www.biomedcentral.com/1471-2261/9/25
Page 7 of 8
(page number not for citation purposes)
effects of visual defect as a comorbidity/complication on
the HRQOL of hypertensive patients has not been com-
monly reported. The presence of a stroke and a visual
impairment increases the extent of disability in hyperten-
sive patients hence worsening their HRQOL.
The data from this study may be subject to Berksonia's bias
as the respondents were all hypertensives who presented in
the hospital with specific complaint. In other to make gener-
alizable conclusions, a population based study using a prob-
ability sampling technique will be recommended to survey
the HRQOL of hypertensives at other meeting points apart
from the hospital. This may give a more objective description
of their HRQOL. Cross cultural content validity of the SF-36
questionnaire was assumed in this study. This presents a
major limitation when comparing the concept of quality of
life in different cultures as the respondents understanding of
the questions might vary. This bias was minimized by ensur-
ing that the interviewers were trained in the questionnaire
administration and the questionnaire was translated into the
local language of the study location with forward and back-
ward translation.
Nevertheless this study provides evidence for a model that
links patients' status with regard to biology, symptoms,
and functionality (HRQOL) and by implication may
prove useful in guiding follow-up of patients who receive
treatment for hypertension. Identification of patient's
Table 8: Multiple regression relating MCS score to predictor variables
MCS Coefficient Beta p-value Lower CL Upper CL
Constant 16.854 0.459 -27.952 61.660
Age -0.124 -0.075 0.291 -0.356 0.108
Edu. status 6.261 0.158 0.040* 0.281 12.241
Marital status -0.166 -0.004 0.953 -5.772 5.439
Occupational class 0.379 0.014 0.852 -3.632 4.391
BMI -0.298 -0.095 0.188 -0.742 0.147
MABP -0.286 -0.170 0.013* -0.511 -0.060
HTN duration 0.109 0.039 0.578 -0.277 0.496
Symptom count 12.035 0.339 0.000* 7.190 16.881
Stroke 21.552 0.250 0.000* 10.166 32.939
Visual impairment 12.599 0.195 0.005* 3.832 21.365
* = significant at < 0.05
Table 9: Multiple regression relating PCS score to predictor variables
PCS score Coefficient Beta p-value Lower CL Upper CL
Constant 44.551 0.000 24.963 64.139
BMI -0.517 -0.180 0.005* -0.879 -0.155
Symptom count 10.546 0.335 0.000* 6.542 14.550
Visual impairment 5.380 0.890 0.155 -2.050 12.810
HTN Duration -0.152 -0.059 0.359 -0.477 0.174
* = significant at < 0.05
Table 10: Multiple regression relating T-QOL score to predictor variables
T-QOL Coefficient Beta p-value Lower CL Upper CL
Constant 28.423 0.100 -5.457 62.304
Edu. status 3.030 0.090 0.230 -1.940 7.999
Marital status 0.327 0.009 0.892 -5.071 4.417
Occupational class -0.263 -0.011 0.880 -3.702 3.177
BMI -0.252 -0.093 0.179 -0.621 0.117
MABP -0.273 -0.188 0.006* -0.466 -0.080
HTN duration -0.040 -0.017 0.814 -0.295 0.375
Symptom count 12.284 0.404 0.000* 8.169 16.399
Stroke 13.551 0.179 0.008* 3.600 23.501
Visual impairment 9.411 0.167 0.015* 1.823 16.399
* = significant at < 0.05BMC Cardiovascular Disorders 2009, 9:25 http://www.biomedcentral.com/1471-2261/9/25
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symptoms, complication/co morbidity and changes in
HRQOL will help clinicians increase their effectiveness in
helping patients maintain adherent behaviour with drug
and non drug interventions in chronic diseases such as
hypertension. Findings from this study shows that the pre-
dictors of HRQOL (blood pressure, symptoms and co
morbidities) in black hypertensive patients are not essen-
tially different from those reported in non-black popula-
tion although the co morbidities and complications in
question are diverse.
Conclusion
Results from this study revealed that none of the socio-
demographic and clinical characteristics of the respond-
ents significantly affected their control of blood pressure,
but the HRQOL was significantly better in the group of
hypertensives that had controlled blood pressure. Blood
pressure and symptoms counts are major predictors of
HRQOL in hypertensives. The presence of Stroke and Vis-
ual defect as a co morbidity or complication are also
major determinant of the HRQOL of hypertensives.
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